Cormorant Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-300,000	Closed	-$20.5M	–	55
2014 Q1	$20.5M	Buy	300,000 +200,000	+200%	+$13.6M	4.71%	4
2013 Q4	$7.04M	Buy	+100,000	New	+$7.04M	2.04%	19